AtriCure, Inc. (ATRC) Covered Calls

AtriCure, Inc. covered calls AtriCure, Inc. is a medical device company, which develops, manufactures and sells innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue.

You can sell covered calls on AtriCure, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ATRC (prices last updated Tue 4:16 PM ET):

AtriCure, Inc. (ATRC) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
36.34 +1.62 21.50 39.00 408K - 1.7
Covered Calls For AtriCure, Inc. (ATRC)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Dec 20 35 0.00 39.00 -10.3% -117.5%
Jan 17 35 1.00 38.00 -7.9% -48.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

AtriCure, Inc. is a medical device company, which develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue for the treatment of atrial fibrillation and systems designed for the exclusion of the left atrial appendage. The company sells its products to hospitals and medical centers globally. It has two primary product lines for cardiac tissue ablation and a product line for left atrial appendage exclusion. The product lines for cardiac tissue ablation are AtriCure's Synergy Ablation System and Related Radio-Frequency Ablation Devices and Cryoablation System. The product line for left atrial appendage exclusion is AtriClip System. AtriCure was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.